Significant Clinical Response to a MEK Inhibitor Therapy in a Patient With Metastatic Melanoma Harboring an Fusion.
作者信息
Kim Kevin B, Semrad Thomas, Schrock Alexa B, Ali Siraj M, Ross Jeffrey S, Singer Mark, Kashani-Sabet Mohammed
机构信息
Kevin B. Kim, Mark Singer, and Mohammed Kashani-Sabet, California Pacific Medical Center Research Institute, San Francisco; Thomas Semrad, Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, CA; Alexa B. Schrock, Siraj M. Ali, and Jeffrey S. Ross, Foundation Medicine, Cambridge, MA; and Jeffrey S. Ross, Albany Medical College, Albany, NY.
出版信息
JCO Precis Oncol. 2018 Nov;2:1-6. doi: 10.1200/PO.17.00138.
PMID:35135096
Abstract
摘要
Zotero 插件